Preface
iii
P/N 85266-30, Manual revision: A
C
ONSUMER
INFORMATION
Proprietary rights
The contents of this manual are property of the Haemonetics
Corporation.
Haemonetics
®
and PCS
®
2 are registered trademarks of the Haemonetics Corpo-
ration. Any information or descriptions contained in this manual may not be
reproduced and released to any of the general public, or used in conjunction with
any professional instruction without written consent of Haemonetics Corpo-
ration, USA. Please direct any written inquiries to the appropriate address:
Legal disclaimer
This manual is intended for use as a guide, uniquely for material as supplied by
the Haemonetics Corporation. It provides the operator with necessary informa-
tion to safely carry out specific procedures and satisfactorily maintain Haemo-
netics-produced equipment. The manual is to be used in conjunction with
instruction and training as supplied by qualified Haemonetics personnel.
Haemonetics guarantees its products when correctly used by a properly trained
operator. Any failure to respect the procedures as described could result in
impaired function of the equipment, as well as in injury to the operator and/or
patient /donor. Haemonetics accepts no responsibility for problems resulting
from failure to comply with prescriptions as outlined by the company. Any modi-
fications estimated as necessary by the customer should be evaluated by a
Haemonetics Clinical Specialist.
Safe utilization of Haemonetics material and equipment requires the operator to
correctly handle and dispose of blood-contaminated material. The operator of
any Haemonetics equipment must understand and implement the local policies
and standard operating procedures concerning the handling of blood-contami-
nated material, as well as blood products.
It remains solely the responsibility of the customer to fully assess and ensure the
safety of any products obtained from Haemonetics prescribed procedures, prior
to further application or use. Haemonetics declines any responsibility for choices
made by the consumer concerning the utilization of products and by-products.
In addition, it is the responsibility of the apheresis center using Haemonetics
equipment and material to inform the donor about the risks involved with any
apheresis procedure. Prior to initiating any procedure, the apheresis center is
responsible to verify that the donor understands these risks and consents to the
procedure.
International Headquarters
Haemonetics S.A.
Signy Center, P.O. Box 262
CH-1274 Signy 2 Switzerland
Tel. +41-22-363-9011
Fax +41-22-363-9054
Corporate Headquarters
Haemonetics Corporation
400 Wood Road
Braintree, MA, 02184, USA
Tel. +1-781-848-7100
Fax +1-781-356-3558
